SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Surgical treatment.
Ann Endocrinol (Paris)
; 83(6): 415-422, 2022 Dec.
Article
em En
| MEDLINE
| ID: mdl-36309207
ABSTRACT
The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician's objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment. The diagnosis and treatment of thyroid nodules requires close collaboration between endocrinologists, nuclear medicine physicians and surgeons, but also involves other specialists. Therefore, this consensus statement was established jointly by 3 societies the French Society of Endocrinology (SFE), French-speaking Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN); the various working groups included experts from other specialties (pathologists, radiologists, pediatricians, biologists, etc.). This section deals with the surgical management of thyroid nodules.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Glândula Tireoide
/
Nódulo da Glândula Tireoide
/
Endocrinologia
/
Medicina Nuclear
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
En
Revista:
Ann Endocrinol (Paris)
Ano de publicação:
2022
Tipo de documento:
Article